High-throughput sequencing or proteomics of different types of tumors reflects the high expression of BAG2 in cancer, including ovarian cancer (17), papillary thyroid carcinoma (18), fibrosarcoma (19) and multiple myeloma (20). This evidence concerns the gene BAG2 and plasma cell myeloma.